As Chief Development Officer at Kuros Biosciences, Philippe Saudan leverages over 20 years of experience in biotech, guiding products from research to clinical stages. He previously served as Chief Scientific Officer at Cytos Biotechnology and holds a PhD from the Swiss Institute for Experimental Cancer Research.
He is a co-inventor on several key patents related to immunotherapies and virus-like particles from his previous research endeavors.
Philippe Saudan
Chief Development Officer (CDO) at Kuros Biosciences
Zurich, Switzerland
Overview
Topics They Care About
Biotech Development
His entire career, from VP of Research to CDO, has been focused on the preclinical and clinical development of biotechnology products.
Orthobiologics
His current role at Kuros Biosciences is centered on developing products for bone healing and spinal fusion, a key area in orthobiologics.
Immunotherapies
He has a deep background in immunology and is a co-inventor on multiple patents for novel immunotherapies developed during his time at Cytos Biotechnology.
Media Appearances
Kuros Biosciences appoints Philippe Saudan as chief development officer. Featured in Reuters
Philippe Saudan, Kuros Biosciences AG: Profile and Biography. Featured in Bloomberg
Kuros appoints Philippe Saudan as Chief Development Officer. Featured in Kuros Biosciences – Press Release (PDF)
Work History
8-2016
Chief Development Officer (CDO) at Kuros Biosciences
2-2016 - 8-2016
Head of Integration at Kuros Biosciences
2-2013 - 2-2016
Chief Scientific Officer at Cytos Biotechnology AG
3-2012 - 2-2013
VP Research & Preclinical Development at Cytos Biotechnology AG
Education
1995 - 1999
Doctor of Philosophy - PhD from Swiss Institute for Experimental Cancer Research
1988 - 1993
Master of Science - MS from University of Zurich
More Information
Social Presence :
Prographics :
Exp : 13
Location : Zurich, Switzerland
Job Level : Leadership
Designation : Chief Development Officer (CDO) at Kuros Biosciences
